URS Study (2025)
- Curative Effect
Endourological treatment of ureteral strictures with the use of self‐expanding stents: is it possible to completely cure the stricture endoscopically? A report on the experience with implantation of 35 stents with a two‐year follow‐up period; a retrospective study
- Demonstrates 80 % cure rate in short strictures < 2 cm and 15 % in longer strictures (full therapeutic success criteria: no tight stenosis in control Renoscintigraphy furosemide test without any stenting)
- 33 patients: 15 patients with short strictures < 2 cm and 18 patients with multiple and/or longer strictures > 2 cm
- Follow-up time post-URS extraction: 2 years
URS Study (2024)
Endoscopic Treatment of Ureteric Strictures Post-Kidney Transplant with AMUS (Prof. Xin Wei, China, 2024)
- Success Rate: 90% (61 out of 68 patients met the success criteria over 1-year follow-up). The definition of surgical success was the unobstructed drainage of the by the URS, or in cases where there was a URS migration, occlusion or encrustation and subsequently removed, there is no worsening of renal hydronephrosis in the patient during the follow-up period
- Patients: 68
- Follow-up: 1 year. The follow-up results of patients at 1 year after implantation were similar to those observed at 1 month after implantation
- Flow Rate Outcome: Significant improvements noted: estimated glomerular filtration rate increased (49.5 → 64.4 mL/min), hydronephrosis volume decreased (not only not worsening as success criteria was defined), creatinine and urea nitrogen levels improved post-surgery
- Adverse Events: Hematuria (18%), pain (10%), UTI (7.4%)
- Migration Rate: 10%
- Encrustation Rate: 1.5%
- Occlusion rate: 2.9%
- Comments: AMUS (Allium Metal Ureteral Stent) proved highly effective. It provided sustained drainage and improved renal metrics in patients for whom traditional ureteroplasty/other stents/dilation had failed or were not feasible
URS Study (2023)
- Curative Effect
Self-expanding large caliber ureteral stents for treatment of idiopathic ureteral stricture
- Success rate of 69%: 29 renal units, didn't experience recurrent strictures
- Total of 42 renal units
- Median follow-up of 16.5 months
URS Study (2023)
Covered Metallic Ureteral Stents for Recurrent UPJO (Dr. Hao Hu, 2023)
- Success Rate: 85% (17 of 20 maintained drainages without failure)
- Patients: 20
- Follow-up: Median 27 months
- Flow Rate Outcome: Renal pelvic width and creatinine significantly improved
- 5 migrated, 1 encrustation, 1 infection
- Conclusion: The new segmental-covered metallic ureteral stent can effectively treat recurrent UPJO, which can relieve hydronephrosis and improve patients’ quality of life.
URS Study (2023)
2-Year Experience with 246 Metal Ureteral Stent Cases (Prof. Wei Xin, 2023)
- Success Rate: 71.7% overall; higher in transplant-related strictures (78.2%)
- Patients: 246
- Follow-up: 2 years
- Flow Rate Outcome: Significant reductions in hydronephrosis, creatinine, and urea nitrogen level
- Adverse Events: Hematuria (7.9%), pain (6.8%), UTI (6.4%)
- Migration Rate: Not reported
- Encrustation Rate: Not reported
- Conclusion: Safe, effective long-term option for various stricture etiologies
URS Study (2023)
Allium Ureteral Stent for Post-Transplant Ureteral Complications (Dr. Neymeyer, Germany, 2023)
- Success Rate: 60% (6 out of 10 patients achieved success defined as no need for additional drainage or surgical revision). The length of the Allium stent was 12 cm in eight patients and 8 cm in two patients.
- Patients: 10
- Follow-up: median stent indwelling time was 11 months), maximum was 23 months.
- Migration Rate: 40% (4/10 patients, all within 3 months); most dislocated stents led to further interventions
- Encrustation Rate: Not reported
- Conclusion: the large-caliber, self-expanding Allium ureteral stent ensures urinary drainage through long-term wall support of the ureter
URS Study (2022)
- Curative Effect
Allium Stent as a Curative Treatment for Benign Ureteric Strictures
- Demonstrates over 85.5 % success in maintaining ureteral lumen patency after stent removal
- 151 patients
- Median follow-up of 18 months
URS Study (2021)
Large-Scale Study on Allium Ureteral Stents (Dr. Xin Wei, 2021)
- Success Rate: 73.2% long-term stent retention (115 of 157 renal units)
- Patients: 147
- Follow-up: Median 15 months
- Flow Rate Outcome: Hydronephrosis, creatinine, and urea nitrogen level significantly improved
- Adverse Events: Hematuria (8.8%), UTI (7.5%), Pain (5.4%)
- Migration Rate: Not reported
- Encrustation Rate: Not reported
- Conclusions: URS was found to be safe and effective for ureteral strictures with a limited complications and good long-term results. For those who are not suitable for surgical reconstruction, the URS is an alternative management
URS Study (2020)
Allium Stents for Uretero-ileal Anastomotic Stricture (Prof. Hu, 2020)
- Success Rate: 100% patency at last follow-up
- Patients: 8 (6 ureteral ileal-conduit strictures and 2 ureteral orthotopic neobladder stricture)
- Follow-up: 9.8 months
- Flow Rate Outcome: significantly improved
- Conclusion: effective for Uretero-ileal Anastomotic Stricture treatment with relatively long-term patency rate and protect renal function. Long indwelling time and improve patient's quality of life.
URS Study (2020)
Allium Stents for Radiation-Induced Ureteral Stricture (Dr. Hu Hao, 2020)
- Success Rate: 94.1% (32 of 34 stents remained effective)
- Patients: 23
- Follow-up: Median 16.5 months
- Flow Rate Outcome: Renal function improved (creatinine decreased significantly)
- Adverse Events: 2 migrations, 2 encrustations
- Conclusion: effective for complex strictures in post-radiation cancer patients
URS Study (2019)
Ureteric Bridging in Severed Ureters with Allium Stents (Dr. Neymeyer, 2019)
- Success Rate: 90.5% complete healing in severed ureter cases. Average bridging distance was 1.6cm (1.1-4.8cm)
- Patients: 7
- Follow-up: Evaluated at 2, 4, and 12 weeks post-procedure. The stent was removed after 4 months
- Adverse Events: there were no complications using URS and grasping forceps. No leakages, discontinuities or scarred strictures were detected in retrograde imaging and URS. Infection or incrustation of the stent was not detected during stent insertion nor during follow up period
- Patient satisfaction was very high
- Conclusion: Using a fully coated polymeric stent is a good option for treating a damaged ureter. Due to the stent properties wound healing was significantly improved and complete healing was achieved without strictures and subsequent interventions in 90.5%
URS Study (2019)
Pumping Probe Technique & Allium Stents for Ureteric Fistulae (Dr. Neymeyer, 2019)
- Success Rate: The cure rate following tissue regeneration using Allium stents was high at 90.5%.
- No strictures were found
- Stents removing after 8-12 weeks
- Migration Rate: Not mentioned
- Conclusion: the subsequent management of ureteric fistulae with stents can be performed gently, safely and quickly
URS Study (2019)
Combined Ureteral and Endovascular Stenting for Arterio-ureteral Fistula (Dr. Neymeyer, 2019)
- Success Rate: 100% of the 8 patients treated were stabilized without complications using Allium ureteral stents alone or in combination with endovascular stents.
- Patients: 8
- Adverse Events: None reported
- Migration Rate: not reported
- Conclusion: Allium URS is a feasible minimal invasive therapeutic option for the treatment of acute life-threatening hemorrhage due to arteriouretral fistulae
URS Study (2017)
The First 100 Cases With Allium Ureteral Stent in the Management of Ureteral Disorders
- 100 patients
- Low migration rate
- Allium ureteral stent can be considered a device that requires a short learning curve, minimal post-operative complications, and lower negative impact on the quality of life of patients
URS Study (2016)
Allium URS – French Multicenter Retrospective Study (Dr. Guandalino, 2016)
- Success Rate: 52.8% of patients had no recurrence of stenosis or fistula after stenting.
- Patients: 36
- Follow-up: Mean follow-up was 7.1 months
- Flow Rate Outcome: Not reported
- Adverse Events: Migration (18.9%), infection (10.8%), intolerance (8.1%)
- Migration Rate: 18.9%
- Encrustation Rate: None reported
URS Study (2014)
Allium URS for Retroperitoneal Fibrosis (Dr. Neymeyer, 2014 – Poster Case Report)
- Clinical improvement observed after bilateral stent placement using “Stent-by-Stent” technique.
- Patients: 1
URS Study (2013)
Allium URS in Ureterovaginal Fistula (Dr. Neymeyer, 2013 – Case Report)
- Success Rate: Clinical success achieved in a patient where JJ-stent had failed; spontaneous healing of the fistula confirmed by urography. One month after the intervention the patient does not report any incontinence during day or night. The flank pain has disappeared completely and the patient was without catheter and free of symptoms
- Patients: 1
- Follow-up: 4 weeks stent indwelling; no long-term recurrence observed post-explanation
- Encrustation Rate: not reported
URS Study (2013)
Allium URS in Ureteral Stenosis (Dr. De Dominicis, 2013)
- Success Rate: 100% success with complete correction of the stenosis and no recurrence during follow-up
- Patients: 12
- Follow-up: Mean follow-up was 10 months post stent removal
- Flow Rate Outcome: Not specified
- Adverse Events: None reported
- Postoperative follow-up didn’t show late complications including migration, encrustation, infection, hematuria or voiding symptoms caused by bladder irritation
- Encrustation Rate: not reported
URS Study (2013)
Multicenter Experience with Allium Ureteral Stent for the Treatment of Ureteral Stricture and Fistula
- 92 patients (107 ureters)
- Mean follow-up – 27 months
- Low migration rate
- Less than 1 % stent obstruction
- Stent can be easily removed
- The use of Allium ureter stents is feasible, safe and effective
URS Study (2013)
Allium Stent for Treatment of Ureteral Stenosis
- 12 patients
- No migration, encrustation, infection, hematuria or voiding symptoms caused by bladder irritation
- No recurrence of stenosis
URS Study (2012)
A New Self-Expanding, Large-Caliber Ureteral Stent: Results of a Multicenter Experience
- 40 patients (49 ureters)
- Up to 63 months indwelling time
- Low migration rate
- Only one stent occluded
- Stent can be easily removed
- All stents were successfully implanted with low rate of migration and with high long-term efficiency
URS Study (2011)
Allium Stents for Upper Urinary Tract Obstruction (Prof. Alefelder, 2011)
- Success Rate: reported technical and clinical success in majority of 17 cases (2 migration cases). All patients were previously on chronic DJ-stenting or nephrostomies. In 1 patient, the drainage of the kidney was insufficient due to poor stent selection. All other patients were asymptomatic after the implantation.
- Patients: 19
- Mean follow-up: 10 months
- Encrustation Rate: None noted
- Conclusion: effective in benign upper tract obstructions
URS Study (2011)
Study Summary: Use of Allium Ureteral Stents for UPJ and Ureteric Strictures (Dr. C. De Dominicis, 2011)
- Success Rate: Clinical success in both patients
- Patients: 2
- Follow-up: 6 months
- Conclusion: Auto expanded Aliium® Stent is an efficacy treatment for management of ureteral stenosis for patients who are not suitable for standard surgery
